Negative ion electrospray ionization (ESI) tandem mass spectrometry (MS/MS) by a quadrupole ion-trap has been utilized to characterize a class of complex oligosaccharide antibiotics (everninomicins), that includes everninomicin-D, SCH 27899, amino everninomicin (SCH 27900), and SCH 49088 containing a hydroxylamino-ether sugar. The deprotonated molecules are dominant ions in the negative ion ESI mass spectra of these compounds. The multiple-stage mass spectrometric analysis (MS n ) of these deprotonated species indicates that the negative charge resides in the deprotonated dichlorophenoxyl group in the substituted aromatic ester ring (ring 1) and the fragmentation occurs remote to this charge site in generating simple sugar sequence-specific fragment ions. One exception to this process is SCH 49088 in which the side chain of the hydroxylamino-ether sugar dominates fragmentation pathway in a charge-driven mechanism and results in less structural information.
Introduction
Everninomicins are an important group of oligosaccharide antibiotics produced by Micromonospora carbonacea 1 , that are highly active against gram-positive bacteria such as methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci [2] [3] [4] . The characteristic structural features of this class of compounds include an eight-sugar backbone with two ortho ester functionalities, a modified nitrosugar, and a completely substituted aromatic ester containing two chlorine atoms.
Although the early structural characterization work on this class of compounds was based on Ganguly-Sarre chemical degradation procedure, [5] [6] [7] fast-atom bombardment (FAB) mass spectrometry (MS) has become a primary method of characterizing everninomicins [8] [9] [10] [11] [12] [13] [14] . However, there are some limitations to this approach, including the limited tandem mass spectrometry (MS/MS) capability for fragmentation pathway studies on sector-based FAB-MS.
Recently, we applied the negative ion FAB-MS and electrospray ionization (ESI) MS for the characterization of everninomicins. 15 The negative ion FAB-MS provided step-wise fragmentation occurring at sugar ether which was most effective in generating structural information. Although negative ion ESI-MS exhibited limited fragmentation for spectral interpretation, it does have advantages in interfacing high performance liquid chromatography (HPLC). For example, we employed a high resolution ESI HPLC/MS to identify several new Ziracin (SCH 27899) related compounds produced during fermentation and degradation process. 16 Ziracin is a member of everninomicin class of antibiotics. These results clearly demonstrated the feasibility of using negative ion ESI-MS to analyze everninomicins. Although no detailed MS/MS studies were carried out to elucidate the negative ion fragmentation mechanism, coupling ESI with a tandem mass spectrometer should allow one to perform step-bystep MS/MS experiments in obtaining structural information and fragmentation mechanisms.
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The recent developments of the quadrupole ion-trap [18] [19] [20] have enabled fragmentation pathways of complex ions to be studied by multiple-stage mass spectrometric analysis (MS n ) through sequential collision-induced dissociation (CID). [21] [22] [23] [24] [25] In a recent paper, we focused on structural characterization of everninomicins by positive ion ESI-MS n analysis that demonstrated the usefulness of this technique. 26 The data suggested in general that a charge-remote fragmentation 27-30 mechanism predominated for sodiated molecules. 26 The sodium cation was found to reside in a central location of the sugar chain and fragmentation occurred to trim the end of the molecule. In this report, we explore the use of negative ion ESI-MS n in a quadrupole ion-trap mass spectrometer for structural characterization of several members of everninomicins that include everninomicin-D (Scheme 1), 2 SCH 27899 (Scheme 2), hydrolyzed SCH 27899 (Scheme 3), amino everninomicin (SCH 27900, Scheme 4) 31 and SCH 49088 containing a hydroxylaminoether sugar (Scheme 5) 32 . The objective of this study is to establish detailed negative ion fragmentation patterns for these compounds by ESI-MS n including locating the position of the negative charge in the molecule. The implications for charge-remote fragmentation are also discussed.
provide adequate structural information of the molecule. The detailed fragmentation information on the deprotonated molecule was obtained by ESI-MS n studies in the ion-trap.
provide adequate structural information of the molecule. The detailed fragmentation information on the deprotonated molecule was obtained by ESI-MS Figure 1 illustrates a three-stage mass analysis from the deprotonated everninomicin-D molecule [M -H] -at m/z 1534. As expected, the dominant fragment ion is at m/z 1487, which is a result of the neutral loss of HNO 2 from ring K ( Figure 1A ). The further fragmentation of the ion at m/z 1487 leads to the product ion at m/z 647, which defines the left portion of the molecule from the central ortho ester group (C) ( Figure 1B 
SCH 27899 SCH 27899
SCH 27899 (Ziracin) is a leading drug candidate in the family of everninomicins. The previous work on positive ion ESI studies on SCH 27899 and other everninomicins indicated that the hydrolysis product ions were prominent in the presence of water and acetic acid. 26 Figure 2 shows negative ion ESI mass spectra of SCH 27899 dissolved in both acetonitrile ( Figure 2A ) and a mixture of water and acetonitrile with 0.1% acetic acid ( Figure 2B ). The base peak in Figure 2A is the deprotonated molecule [M -H] -at m/z 1628, whereas the base peak in Figure   2B is the deprotonated hydrolysis product [M + H 2 O -H] -at m/z 1646. The structure of SCH 27899 hydrolysis product is illustrated in Scheme 3. It is well documented in the literature that SCH 27899 can undergo sequential hydrolysis at both ortho ester groups with the initial hydrolysis occurring at the central ortho ester group. 11 The presence of molecular ions as well as hydrolysis product ions has complicated the ESI mass spectra for data interpretation. The most effective way of deriving structural information from fragmentation is to perform tandem mass spectrometric experiments in a multiple-stage fashion.
SCH 27899 (Ziracin) is a leading drug candidate in the family of everninomicins. The previous work on positive ion ESI studies on SCH 27899 and other everninomicins indicated that the hydrolysis product ions were prominent in the presence of water and acetic acid. 26 Figure 2 shows negative ion ESI mass spectra of SCH 27899 dissolved in both acetonitrile ( Figure 2A ) and a mixture of water and acetonitrile with 0.1% acetic acid ( Figure 2B ). The base peak in Figure 2A is the deprotonated molecule [M -H] -at m/z 1628, whereas the base peak in Figure   2B is the deprotonated hydrolysis product [M + H 2 O -H] -at m/z 1646. The structure of SCH 27899 hydrolysis product is illustrated in Scheme 3. It is well documented in the literature that SCH 27899 can undergo sequential hydrolysis at both ortho ester groups with the initial hydrolysis occurring at the central ortho ester group. 11 The presence of molecular ions as well as hydrolysis product ions has complicated the ESI mass spectra for data interpretation. The most effective way of deriving structural information from fragmentation is to perform tandem mass spectrometric experiments in a multiple-stage fashion. In the case of the hydrolysis product of SCH 27899, the fragmentation of negative ions generated much less sequence-specific ions under similar activation conditions (Scheme 3). The conversion of the ortho ester to an ester group drastically alters the fragmentation pattern. For example, the fragmentation pattern of ions at m/z 1496 (derived from m/z 1646 → m/z 1496, Figure 4 ) from the hydrolysis product is quite different from that of the corresponding ions at m/z 1478 (derived from m/z 1628 → m/z 1478, Figure 3B ) from SCH 27899. The base peak in Figure  4 is at m/z 694, whereas the base peak in Figure 3B is at m/z 1431. A simple bond cleavage of the ester in the hydrolysis site is much more favored than the cleavage of the central ortho ester group in SCH 27899. As in the case of everninomicin-D, the negative charge is most likely to be retained in ring 1 with deprotonation taking place on the acidic -OH group. Similar process is taking place in the case of its hydrolyzed molecule. It is interesting to note that deprotonation does not occur at any of the phenolic groups on aromatic ester ring 2 presumably because the phenolic group in ring 1 is more acidic.
Amino Everninomicin (SCH 27900) Amino Everninomicin (SCH 27900)
Amino everninomicin is a minor component isolated from the fermentation broth. 
Conclusions
The negative ion ESI-MS has been found to be effective in generating abundant molecular ions for several complex oligosaccharides (everninomicins), including everninomicin-D, SCH 27899, amino everninomicin, and SCH 49088. ESI-MS n studies of the deprotonated molecules provided detailed structural information involving sugar sequences. This study demonstrated that the negative charge was localized on the more acidic phenolic function of the substituted aromatic ring containing two chlorine atoms. The anionic species appear to undergo fragmentation remote to the charge site. In the case of SCH 49088 that contains a hydroxylamino-ether sugar, much less structurally informative fragment ions were observed. This may because deprotonation is more likely to occur on the carboxyl group of the subunit. Subsequently, it led to a charge-driven process for majority of the fragment ions produced. This strategy of employing negative ion ESI-MS n to characterize everninomicins can potentially provide a rapid method to probe chemically modified analogues by investigating their detailed fragmentation patterns. 
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Experimental Section
General Procedures. Everninomicin-D, SCH 27899, amino everninomicin (SCH 27900), and SCH 49088 were obtained from the fermentation of Micromonospora carbonacea (ScheringPlough Research Institute, Kenilworth, NJ, USA). The procedures were described previously elsewhere. 2, 11, 31, 32 All experiments were carried out on a Finnigan LCQ-deca (San Jose, CA, USA) ion-trap mass spectrometer equipped with an electrospray ionization source. The sample solution was introduced into the ESI source by direct infusion at a flow rate of 5 µl/min. The electrospray needle was held at 4.1 kV, and a 20 Psi nitrogen sheath gas was used to stabilize the spray. The heated capillary was set at 250 o C. The helium was introduced into the ion trap to improve the trapping efficiency of the trap including its use as the collision gas during CID. The operational pressure after introducing helium was at 1.4x10 -5 torr.
The instrument was operated in the negative ion mode with the conversion dynode voltage at 15 kV. A typical set of experimental parameters included a maximum ion injection time of 250 ms and 3 microscans per analytical scan. In MS n experiments, the standard resonance excitation was employed. The typical q value was set at 0.25 and activation time at 30 ms was used. The isolation width was typically at 1.5 Dalton/charge. The activation amplitude, represented as a percentage of full activation voltage, was optimized to facilitate fragmentation of certain ions.
